Autophagy-mediated NCOR1 degradation is required for brown fat maturation and thermogenesis.


Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
03 2023
Historique:
pubmed: 11 8 2022
medline: 3 3 2023
entrez: 10 8 2022
Statut: ppublish

Résumé

Brown adipose tissue (BAT) thermogenesis affects energy balance, and thereby it has the potential to induce weight loss and to prevent obesity. Here, we document a macroautophagic/autophagic-dependent mechanism of peroxisome proliferator-activated receptor gamma (PPARG) activity regulation that induces brown adipose differentiation and thermogenesis and that is mediated by TP53INP2. Disruption of TP53INP2-dependent autophagy reduced brown adipogenesis in cultured cells.

Identifiants

pubmed: 35947488
doi: 10.1080/15548627.2022.2111081
pmc: PMC9980505
doi:

Substances chimiques

PPAR gamma 0
TP53INP2 protein, human 0
Nuclear Proteins 0
NCOR1 protein, human 0
Nuclear Receptor Co-Repressor 1 0
Ncor1 protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

904-925

Subventions

Organisme : Medical Research Council
ID : MC_UU_12012/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802051
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400192
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/7/33636
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/12/53/29714
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/2
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Cell Metab. 2019 Jan 8;29(1):27-37
pubmed: 30503034
Nat Commun. 2019 Apr 5;10(1):1566
pubmed: 30952952
Biostatistics. 2003 Apr;4(2):249-64
pubmed: 12925520
Nat Cell Biol. 2018 Apr;20(4):443-454
pubmed: 29593329
Nat Commun. 2019 Apr 5;10(1):1567
pubmed: 30952864
PLoS One. 2012;7(3):e34034
pubmed: 22470510
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Methods. 2019 Mar 15;157:106-114
pubmed: 30419335
FEBS Lett. 2012 Sep 21;586(19):3179-86
pubmed: 22750142
N Engl J Med. 2009 Apr 9;360(15):1518-25
pubmed: 19357407
Animals (Basel). 2019 Dec 02;9(12):
pubmed: 31810209
PLoS One. 2009 Dec 24;4(12):e8458
pubmed: 20107496
EMBO Rep. 2013 Sep;14(9):795-803
pubmed: 23907538
J Nutr. 1984 Jun;114(6):1151-8
pubmed: 6726479
Biochimie. 2017 Mar;134:127-137
pubmed: 28109720
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Nature. 2010 Dec 23;468(7327):1100-4
pubmed: 21179166
PLoS Biol. 2017 Aug 1;15(8):e2002176
pubmed: 28763438
Ann Appl Stat. 2014 Mar;8(1):309-330
pubmed: 24795787
Genome Biol. 2008;9(2):R26
pubmed: 18248669
Nat Commun. 2020 May 8;11(1):2306
pubmed: 32385399
Nat Med. 2013 May;19(5):635-9
pubmed: 23603815
EMBO Rep. 2010 Jan;11(1):37-44
pubmed: 20010805
Mol Biol Cell. 2009 Feb;20(3):870-81
pubmed: 19056683
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5523-8
pubmed: 22427360
Nat Rev Mol Cell Biol. 2005 Jul;6(7):542-54
pubmed: 15957004
Physiol Rep. 2016 May;4(10):
pubmed: 27230905
Mol Cell Biol. 2001 Jan;21(1):319-29
pubmed: 11113206
Mol Cell. 2015 Feb 5;57(3):456-66
pubmed: 25601754
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
J Clin Invest. 2009 Nov;119(11):3329-39
pubmed: 19855132
Nat Med. 2021 Jan;27(1):58-65
pubmed: 33398160
J Cell Sci. 1997 Apr;110 ( Pt 7):801-7
pubmed: 9133667
Pharmacol Res. 2009 Apr;59(4):221-34
pubmed: 19429463
Am J Physiol. 1986 Mar;250(3 Pt 1):E274-81
pubmed: 3953813
Cell Metab. 2012 Dec 5;16(6):814-24
pubmed: 23217260
Mol Cell. 1999 Oct;4(4):585-95
pubmed: 10549290
Endocrinology. 2006 Dec;147(12):5708-14
pubmed: 16980437
Genome Biol. 2004;5(10):R80
pubmed: 15461798
Autophagy. 2019 Aug;15(8):1309-1321
pubmed: 30767704
N Engl J Med. 2009 Apr 9;360(15):1500-8
pubmed: 19357405
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4401-6
pubmed: 17360536
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14457-62
pubmed: 14603033
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
J Clin Invest. 2014 May;124(5):1914-27
pubmed: 24713655
J Clin Invest. 2013 Jan;123(1):469-78
pubmed: 23257354
J Exp Biol. 2011 Jan 15;214(Pt 2):242-53
pubmed: 21177944
Am J Physiol Endocrinol Metab. 2007 Aug;293(2):E444-52
pubmed: 17473055
Cell Metab. 2015 Jan 6;21(1):33-8
pubmed: 25565203
Hepatology. 2012 Jun;55(6):1727-37
pubmed: 22183976
Nature. 1997 May 1;387(6628):94-7
pubmed: 9139828
PLoS One. 2007 Nov 21;2(11):e1183
pubmed: 18030323
Biochim Biophys Acta. 2005 May 30;1740(2):293-304
pubmed: 15949696
Nat Commun. 2021 May 17;12(1):2876
pubmed: 34001883
Autophagy. 2017 Jan 2;13(1):169-186
pubmed: 27846372
Handb Clin Neurol. 2018;156:137-152
pubmed: 30454587
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
N Engl J Med. 2009 Apr 9;360(15):1509-17
pubmed: 19357406
Cell Metab. 2014 Apr 1;19(4):593-604
pubmed: 24703692
Biochem J. 2005 Jul 1;389(Pt 1):47-56
pubmed: 15762841
Bioinformatics. 2015 Jun 15;31(12):2032-4
pubmed: 25697820
Obesity (Silver Spring). 2015 Jul;23(7):1450-9
pubmed: 26053335

Auteurs

Alba Sabaté-Pérez (A)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain.

Montserrat Romero (M)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain.

Paula Sànchez-Fernàndez-de-Landa (P)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain.

Stefania Carobbio (S)

Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Bases Moleculares de Patologías Humanas, Centro de Investigacion Principe Felipe, Valencia, Spain.

Michail Mouratidis (M)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.

David Sala (D)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain.

Pablo Engel (P)

Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Paula Martínez-Cristóbal (P)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Josep A Villena (JA)

CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain.
Laboratory of Metabolism and Obesity, Vall d'Hebron-Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain.

Sam Virtue (S)

Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.

Antonio Vidal-Puig (A)

Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, Cambridgeshire, UK.

Manuel Palacín (M)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Xavier Testar (X)

Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain.

Antonio Zorzano (A)

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH